EichorEICHOR
Study identifier: NCT06383390 Synced from ClinicalTrials.gov · August 02, 2026
● Active Not Recruiting

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

Condition: Atherosclerotic Cardiovascular Disease (ASCVD) · Chronic Kidney Disease (CKD)  ·  Sponsor: Eli Lilly and Company

PhasePhase 3
Planned participants10000
Who can joinAll sexes, 45 Years to no upper limit
Healthy volunteersNo

About this study

The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/m\^2 or higher and Atherosclerotic Cardiovascular Disease and/or chronic kidney disease. The study will last for about 5 years. Participants will have up to 27 clinic visits with the study doctor.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (743)

Alabama Kidney ResearchAlabaster, Alabama, United States
Central Research AssociatesBirmingham, Alabama, United States
Alliance for Multispecialty Research, LLCDaphne, Alabama, United States
Nephrology ConsultantsHuntsville, Alabama, United States
Alliance for Multispecialty Research, LLCMobile, Alabama, United States
Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLCGilbert, Arizona, United States
Sun City Clinical ResearchGlendale, Arizona, United States
Arizona Kidney Disease & Hypertension Center (AKDHC) - ThunderbirdGlendale, Arizona, United States
Helios Clinical Research - SAZ-PDV-026Paradise Valley, Arizona, United States
Banner University Medical Center PhoenixPhoenix, Arizona, United States
Phoenix Clinical LLCPhoenix, Arizona, United States
Elite Clinical Studies, LLCPhoenix, Arizona, United States

+ 731 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →